BenevolentAI S.A. (BAI.AS)
EUR 0.4
(-4.31%)
EUR 0.4
(-4.31%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 7.33 Million GBP | -30.58% |
| 2022 | 10.56 Million GBP | 128.32% |
| 2021 | 4.62 Million GBP | -33.04% |
| 2020 | 6.9 Million GBP | 48.83% |
| 2019 | 4.64 Million GBP | -32.01% |
| 2018 | 6.82 Million GBP | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 7.33 Million GBP | -30.58% |
| 2022 FY | 10.56 Million GBP | 128.32% |
| 2021 FY | 4.62 Million GBP | -33.04% |
| 2020 FY | 6.9 Million GBP | 48.83% |
| 2019 FY | 4.64 Million GBP | -32.01% |
| 2018 FY | 6.82 Million GBP | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ABIONYX Pharma SA | 618 Thousand EUR | -1086.246% |
| ABIVAX Société Anonyme | 3.91 Million EUR | -87.302% |
| Adocia SA | 1.38 Million EUR | -429.314% |
| Aelis Farma SA | 12.35 Million EUR | 40.678% |
| Biophytis S.A. | -803 Thousand EUR | 1012.951% |
| Advicenne S.A. | 1.42 Million EUR | -414.095% |
| genOway Société anonyme | 20.1 Million EUR | 63.528% |
| IntegraGen SA | 5.01 Million EUR | -46.086% |
| Medesis Pharma S.A. | -2.66 Million EUR | 375.108% |
| Neovacs S.A. | 29.31 Thousand EUR | -24908.528% |
| NFL Biosciences SA | -56.06 Thousand EUR | 13176.127% |
| Plant Advanced Technologies SA | 2.15 Million EUR | -240.515% |
| Quantum Genomics Société Anonyme | -1.41 Million EUR | 616.526% |
| Sensorion SA | 3.78 Million EUR | -93.539% |
| Theranexus Société Anonyme | -4.63 Million EUR | 258.04% |
| TME Pharma N.V. | -127 Thousand EUR | 5872.441% |
| Valbiotis SA | 2.66 Million EUR | -174.775% |
| TheraVet SA | -530.79 Thousand EUR | 1481.133% |
| Valerio Therapeutics Société anonyme | 1.26 Million EUR | -478.611% |
| argenx SE | 925.49 Million EUR | 99.208% |
| BioSenic S.A. | 543 Thousand EUR | -1250.092% |
| Celyad Oncology SA | 33 Thousand EUR | -22115.152% |
| DBV Technologies S.A. | 4.15 Million EUR | -76.243% |
| Galapagos NV | 203.73 Million EUR | 96.402% |
| Genfit S.A. | 28.22 Million EUR | 74.026% |
| GeNeuro SA | -293.8 Thousand EUR | 2595.235% |
| Hyloris Pharmaceuticals SA | 1.99 Million EUR | -267.653% |
| Innate Pharma S.A. | -4.12 Million EUR | 277.894% |
| Inventiva S.A. | 17.5 Million EUR | 58.109% |
| MaaT Pharma SA | 1.65 Million EUR | -342.961% |
| MedinCell S.A. | 9.28 Million EUR | 21.07% |
| Nanobiotix S.A. | 36.2 Million EUR | 79.753% |
| Onward Medical N.V. | -14.81 Million EUR | 149.474% |
| Oryzon Genomics S.A. | 13.94 Million EUR | 47.44% |
| OSE Immunotherapeutics SA | 2.22 Million EUR | -229.187% |
| Oxurion NV | 104 Thousand EUR | -6949.038% |
| Pharming Group N.V. | 220.1 Million EUR | 96.669% |
| Poxel S.A. | 1000.00 EUR | -733000.0% |
| GenSight Biologics S.A. | 3 Million EUR | -144.367% |
| Transgene SA | -28.4 Million EUR | 125.81% |
| Financière de Tubize SA | -2.02 Million EUR | 461.207% |
| UCB SA | 3.34 Billion EUR | 99.781% |
| Valneva SE | 52.83 Million EUR | 86.125% |
| Vivoryon Therapeutics N.V. | -3.09 Million EUR | 336.866% |